Larvol Delta - AIVITA-completes-treatment-of-first-patient-in-phase-2-ovarian-cancer-trial

ovapuldencel-T (AVOVA-1) - Caladrius, AiVita Biomedical

https://www.prnewswire.com/news-releases/aivita-completes-treatment-of-first-patient-in-phase-2-ovarian-cancer-trial-300799941.html

Feb 21, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next